All Curated Mutation Sites in CHIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in CHIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
6K
  
C
  
E1
  
E2
  
E3
  
nsP1
  
nsP2
  
nsP3
  
nsP4
  
Pol
  

Keyword: Chikungunya Fever-24465661
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24465661 V756I
6K
Chikungunya Fever
G
R
L
View
2 24465661 P23S
C
Capsid
Chikungunya Fever
G
R
L
View
3 24465661 V27I
C
Capsid
Chikungunya Fever
G
R
L
View
4 24465661 A226V
E1
E1
Chikungunya Fever
G
R
L
View
5 24465661 D1093E
E1
E1
Chikungunya Fever
G
R
L
View
6 24465661 V1167A
E1
E1
Chikungunya Fever
G
R
L
View
7 24465661 S700T
E2
E2
Chikungunya Fever
G
R
L
View
8 24465661 T637M
E2
E2
Chikungunya Fever
G
R
L
View
9 24465661 V711A
E2
E2
Chikungunya Fever
G
R
L
View
10 24465661 M314L
nsP1
nsP1
Chikungunya Fever
G
R
L
View
11 24465661 Q488R
nsP1
nsP1
Chikungunya Fever
G
R
L
View
12 24465661 T128K
nsP1
nsP1
Chikungunya Fever
G
R
L
View
13 24465661 T376M
nsP1
nsP1
Chikungunya Fever
G
R
L
View
14 24465661 A1328V
nsP2
nsP2
Chikungunya Fever
G
R
L
View
15 24465661 S589N
nsP2
nsP2
Chikungunya Fever
G
R
L
View
16 24465661 P1804S
nsP3
nsP3
Chikungunya Fever
G
R
L
View
17 24465661 T1670I
nsP3
nsP3
Chikungunya Fever
G
R
L
View
18 24465661 Y1550H
nsP3
nsP3
Chikungunya Fever
G
R
L
View
19 24465661 T1938A
nsP4
nsP4
Chikungunya Fever
G
R
L
View
20 24465661 T2117A
nsP4
nsP4
Chikungunya Fever
G
R
L
View
Contents
Description

The table shows all curated mutation sites of CHIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.